Metanálise mostra que a prevalência geral de intolerância à estatina é de cerca de 9% e identifica os fatores de risco mais comuns.
17 Fev, 2022 | 15:31hPrevalence of statin intolerance: a meta-analysis – European Heart Journal
Comentários:
Expert reaction to study looking at statin intolerance – Science Media Centre
Conteúdos relacionados:
Comentário no Twitter
Statin intolerance is “over-estimated and over-diagnosed”. World’s largest study shows less than 10% suffer side-effects caused by statins https://t.co/pcVk8YI3I3@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #Riskfactors pic.twitter.com/b3nFWsc74d
— European Society of Cardiology Journals (@ESC_Journals) February 16, 2022